학술논문

Evaluation of neurological changes in secondary progressive multiple sclerosis patients treated with immune modulator MIS416: results from a feasibility study
Document Type
Report
Source
Pilot and Feasibility Studies. November 16, 2017, Vol. 3 Issue 1
Subject
Medical research
Medicine, Experimental
Multiple sclerosis -- Development and progression -- Care and treatment -- Diagnosis -- Analysis
Immune response -- Research
Treatment outcome -- Research
Immunity -- Dosage and administration -- Testing
Clinical trials -- Methods
Language
English
ISSN
2055-5784
Abstract
Author(s): Gill A. Webster[sup.1] , Dalice A. Sim[sup.2] , Anne C. La Flamme[sup.3] and Nancy E. Mayo[sup.4] Background Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous [...]